Related Experiment Video
Updated: Dec 31, 2025

02:28
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
708
Risankizumab vs. adalimumab for moderate-to-severe plaque psoriasis: a critical appraisal
A Al-Janabi1,2, R B Warren1,2
1The Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester NIHR Biomedical Research Centre, Manchester Academic Health Science Centre, Manchester, M6 8HD, U.K.
The British Journal of Dermatology
|January 4, 2020
Abstract
No abstract available in PubMed .

